Nurx logo

Nurx Review

Best for: mainstream telehealth GLP-1 access

Established women's telehealth brand offering tiered GLP-1 weight loss programs.

By Eli Marsden · Founding Editor
Editorially reviewed (not clinically reviewed) · How we verify contentLast reviewed
7.4
★★★3.7
CompoundedSemaglutideTirzepatide
$179/mo

What the monthly price covers

Medication

Billed separately

Provider visits

Billed separately

Shipping

Not disclosed

Lab work

Not disclosed

Coaching

Not disclosed

See plans →

No insurance neededVetted by our editors

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

The Bottom Line

Nurx is a solid telehealth option with balanced features and pricing.

Score: 7.4/10Best for: mainstream telehealth GLP-1 accessFrom: $179/mo
Nurx logo
3.7 / 5
Our editorial rating
Visit Nurx

from $179/mo · no insurance needed

Nurx at a glance

Type
GLP-1 telehealth provider
Medications
Semaglutide, Tirzepatide
Starting price
$179/mo (Range up to $299/mo)
FDA status
No FDA warning letter on record

How we scored Nurx

Each dimension is scored algorithmically from Nurx’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.

Value25%

7.1/10

At $179/mo, Nurx runs about 6% above the $170 median for GLP-1 providers.

Effectiveness25%

8.4/10

Nurx offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.

User Experience15%

7.2/10

Online intake and platform experience; 3 platform features disclosed.

Trust & Safety15%

7.6/10

Core details confirmed by our editors; no FDA warning letters on file (last checked 2026-06-03).

Accessibility10%

6.4/10

Nurx's exact state footprint isn't published — confirm coverage in your state before signing up.

Support10%

6.2/10

Nurx provides standard clinician follow-up; no extended coaching or community program is disclosed.

How we verified this Nurx review

Last checked 2026-06-03
  • Confirmed current pricing across 2 dose/plan tiers
  • Confirmed what the monthly price does and doesn't include
  • Checked the FDA warning-letter database for enforcement actions
  • Walked the public intake/checkout flow on the provider's site

Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.

GLP-1 medications Nurx offers

Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.

Pricing

StartingCompounded
$179/mo
semaglutide

Range up to $299/mo

StartingCompounded
$179/mo
tirzepatide

Range up to $299/mo

Ready to get started?

Plans and promotions change often — check Nurx's current pricing and active discounts before you decide.

See Nurx pricing →

What we like

  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Watch-outs

  • Limited public information on program details

Nurx for GLP-1: a familiar name with an unfamiliar pricing structure

Nurx is one of the better-known names in direct-to-consumer telehealth, built originally around women's health — birth control, PrEP, dermatology — before adding GLP-1 weight management. That brand recognition is the main reason it lands on most people's shortlists, and it's a fair reason: this is an established operator, not a six-month-old storefront. But once you look past the logo, the weight-loss program works very differently from the compounded-injection services it gets grouped with, and that difference is the whole story for anyone deciding whether Nurx belongs on their list.

This is a brand-name program, not a compounded one

The single most important fact about Nurx's GLP-1 offering, as of our latest verification, is that it dispenses brand-name pens only — there is no compounded semaglutide or tirzepatide here. That puts Nurx in a fundamentally different bucket from the compounding-pharmacy services that advertise a single low all-in monthly figure. With Nurx, the provider writes you a prescription and you pick up and pay for the medication at your own local pharmacy. Nurx is selling you the clinical access and the prescription, not the drug itself.

If you have seen an older price for Nurx in the low couple-hundreds per month, set it aside. That figure reflected a compounded model the service no longer runs. The current reality is closer to a true insurance-or-cash brand experience, and the numbers are far higher because the pharmacy counter, not Nurx, sets the medication price.

How the money actually adds up

Nurx splits its program into two separate charges, and it's important to read them as additive rather than bundled:

  • An initial consultation fee charged when you first sign up and get evaluated.
  • A recurring monthly provider-support fee that keeps your prescription and clinical follow-up active.
  • The medication itself, billed separately by your local pharmacy — for brand-name GLP-1 pens paid in cash, that lands in the high hundreds to well over a thousand dollars a month.

In other words, the fees you pay Nurx are modest two-figure amounts, but they are not the real cost of the program. The real cost is the brand-name drug, and unless you have commercial insurance that covers Wegovy or Zepbound, that drug price is what will dominate your monthly outlay. That's not a knock on Nurx specifically — it's the nature of any brand-name telehealth route — but it's the part most likely to surprise someone who came in expecting an all-inclusive compounded rate.

Who Nurx is genuinely a good fit for

Nurx makes the most sense for a specific kind of patient: someone who wants brand-name semaglutide or tirzepatide, likely has insurance that will absorb most of the pharmacy cost, and values dealing with a long-established, recognizable telehealth company over a newer compounding-focused startup. For that person, the modest consult and support fees are a reasonable price to unlock a prescription and ongoing clinical oversight, and the local-pharmacy pickup is a feature, not a bug — you use the pharmacy and coverage you already have.

It also suits people who are specifically uneasy about compounded GLP-1s and want only FDA-approved, brand-name pens. Nurx gives you that by default, which some competitors don't.

Who should look elsewhere

If you're paying cash and your goal is the lowest realistic monthly cost, Nurx is probably the wrong tool. Cash patients are almost always better served by a compounding-pharmacy service that bundles the medication into one predictable monthly price, often a small fraction of brand-name cash cost. Routing through Nurx means paying its fees on top of full pharmacy pricing — the worst of both worlds for an uninsured budget.

You should also go in expecting to do some homework. Nurx does not publish a detailed state-availability list — its own site only notes that services aren't offered everywhere — and the weight-loss program details are thinner online than what you'll find from providers that lay out dose ladders and totals up front. Confirm that it operates in your state and that your insurance covers your specific drug before you pay the consultation fee.

Trust, oversight, and what we can verify

On the safety side, Nurx carries no FDA warning letters in our records, and as a brand-name-only program it sidesteps the compounding-quality questions that follow some cash-model competitors — the pens come from the same manufacturers as any pharmacy-filled prescription. Working against full confidence is transparency: the public program documentation is limited, the state list isn't disclosed, and we had to confirm the current brand-only model and fee structure directly rather than from a clear pricing page. We rate the underlying operation as legitimate and established, but the published detail is below what the most transparent providers offer. See our scoring methodology for how we weigh verification confidence.

The bottom line

Nurx is a credible, well-known telehealth brand that has quietly become a brand-name GLP-1 access route — small fees to Nurx, full freight to your pharmacy. If you're insured and want recognized, FDA-approved pens through a name you trust, it's a sensible pick. If you're paying out of pocket and chasing the lowest sticker price, a bundled compounded service will almost certainly beat it. Either way, ignore any old low compounded figure attached to Nurx; confirm the current fees, your state, and your drug coverage before you commit.

Worth pricing against Sunlight ($159/month) and Bodybuilding Health+ ($179/month) before you commit — both sit close to Nurx on cost and formulation.

Ready to start with Nurx?

Starting at $179/month. See current pricing and start your free consultation.

Alternatives to Nurx

8.6/ 10
Verified partner

Enhance MD

Best for: lab-monitored compounded GLP-1 with mandatory video visit

★★★★4.3

Editorial score · methodology

$49/mo
CompoundedSemaglutideTirzepatide
Get StartedRead full Enhance MD review →
8.5/ 10
Verified partner

Embody

Best for: lowest first-month entry pricing on compounded GLP-1s

★★★★4.3

Editorial score · methodology

$99/mo
CompoundedSemaglutideTirzepatide
Get StartedRead full Embody review →
8.5/ 10
Verified partner

TrimRx

Best for: best overall value

★★★★4.3

Editorial score · methodology

$179/mo
CompoundedSemaglutide
Get StartedRead full TrimRx review →

Frequently Asked Questions

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Sources

The primary regulatory filings and peer-reviewed studies cited throughout this Nurx review:

Sources & methodology — as of July 2026
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy FrameworkU.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)U.S. Food & Drug Administration.
  4. 4.PCAB — Pharmacy Compounding Accreditation Board StandardsAccreditation Commission for Health Care (ACHC) / PCAB.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)Kaiser Family Foundation.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)New England Journal of Medicine.PMID: 33567185.
  7. 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDAU.S. Food & Drug Administration.
  8. 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDAU.S. Food & Drug Administration.
  9. 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)New England Journal of Medicine.PMID: 35658024.
  10. 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDAU.S. Food & Drug Administration.
  11. 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDAU.S. Food & Drug Administration.
  12. 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)New England Journal of Medicine.PMID: 40334173.

Ready to start with Nurx?

Starting at $179/month. See current pricing and start your free consultation.